Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line

This publication has 11 references indexed in Scilit:

• Anthracycline Antibiotics in Cancer Therapy
  Drugs, 1994
• Reversal of P-glycoprotein-associated multidrug resistance: The challenge continues
  European Journal Of Cancer, 1993
• Clinical trials of agents that reverse multidrug resistance. A literature review
  Cancer, 1993
• Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells
  British Journal of Cancer, 1993
• The role of reduced growth rate in the development of drug resistance of HOB1 lymphoma cells to vincristine
  Cancer Letters, 1993
• Cell cycle dependent uptake and release of anthracycline by drug-resistant and drug-sensitive human leukaemic K562 cells
  Biochemical Pharmacology, 1993
• Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistance
  European Journal Of Cancer, 1992
• Drug resistance in oncology: from concepts to applications
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1992
• Potentiation of etoposide cytotoxicity against a human ovarian cancer cell line by pretreatment with non-toxic concentrations of methotrexate or aphidicolin
  European Journal Of Cancer, 1992
• Pleiotropic-resistant phenotype is a multifactorial phenomenon in human colon carcinoma cell lines
  British Journal of Cancer, 1991